Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared Michael Torres‘s post on X, adding:
“A surge in dual-payload conjugates
List of dual-payload ADCs to be presented at AACR25.”
Quoting Michael Torres’s post:
“AACR25 preview – a surge in dual-payload conjugates
Worth a re-read…I’m very curious to see what folks have…Top1i + Tubulin isn’t the way to go in our view. We’ve seen antagonism or simply no benefit adding Top1i to MMAE as an example. Hope folks show single payload versions.”
More posts featuring AACR25.